- Beretta leaves Maryland over gun laws, heads for Tennessee
- Neal Boortz defends Hillary Clinton for representing child rapist
- House task force to recommend National Guard on border, faster deportations
- Top federal judge uses pizza to explain complex Obamacare situation
- Obama, Biden overhaul job training programs
- Drought-plagued Californians turn to paint to keep lawns green
- ISIL now forcing Iraqi shopkeepers to veil mannequins in Mosul
- 11 parents of Nigeria’s abducted girls die
- Genetic mapping triggers new hope on schizophrenia
- Turkish P.M. Erdogan won’t speak to Obama, but he’ll take calls from Biden
FDA panel wants more restrictions on painkillers
Question of the Day
WASHINGTON (AP) - Federal health advisers said Friday a government proposal to curb misuse of powerful painkillers does not go far enough to fix a problem linked to hundreds of fatal overdoses annually.
The Food and Drug Administration summoned a panel of 35 outside experts to review its plan to reduce the misuse and abuse of long-acting pain relievers. The agency’s plan consists mainly of educating doctors and patients about appropriate use of the drugs.
But the FDA panel voted 25-10 to reject the agency’s proposal, saying more requirements and training are needed for health professionals who prescribe the drugs.
The government’s proposal would apply to extended release versions of opioid narcotics like morphine, oxycodone and methadone.
In one key disagreement with the FDA, panelists said doctors who prescribe opioids should be required to undergo training. The FDA suggested in its briefing that making such training mandatory could be overly burdensome, since the drugs are prescribed by thousands of physicians across the U.S.
Panelists also questioned whether the FDA’s so-called “risk evaluation and mitigation strategy,” or REMS, would have any significant impact on the epidemic of opioid abuse, which is responsible for more fatal overdoses each year than heroin and cocaine combined.
Dr. John Jenkins, the director of the FDA’s office of new drugs, said the agency’s plan was designed to address legitimate use of the drugs, not deliberate abuse.
“We freely acknowledged that the REMS cannot address the entire scope of the problems for society on prescription drug misuse and abuse,” Jenkins told reporters in a post-meeting news conference.
Jenkins said the FDA would review the panel’s recommendations and adjust its plan in coming months.
The government’s risk management plan is specific to extended release versions of opioid drugs, which come in both pill and patch forms and are designed to give long-lasting effects. That potency carries serious risks when patients abuse them as stimulants.
Some panelists suggested FDA restrictions should also expand to more conventional, immediate-release painkillers.
The FDA has issued a number of warnings on prescription pain relievers in recent years but with little success. A federal survey conducted in 2007 found 5.2 million people in the U.S. reported using prescription pain drugs inappropriately.
The companies most likely to be impacted by new regulations include Purdue Pharmaceuticals, maker of the blockbuster pill OxyContin, and King Pharmaceuticals, which markets Embeda morphine capsules.
TWT Video Picks
The president could pay the full price for ignoring Congress
- IRS seeks help destroying another 3,200 computer hard drives
- David Perdue defeats Jack Kingston in Georgia Republican Senate primary runoff
- D.C. appeals panel deals big blow to Obamacare subsidies
- 'Straight White Guy Festival' supposedly set for Ohio park
- BERMAN & MADYOON: An Iranian-Turkish reset
- Beretta moving to Tennessee over Maryland gun laws
- Pentagon team dispatched to Ukraine amid crisis with Russia
- Ron Paul: U.S. partly to blame for Malaysia Airlines disaster
- CARSON: Costco and the perils of mixing politics and business
- Gen. James Amos, Marine Corps commandant, slams Obama's handling of Iraq
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq